Ground News

Don't Just Read the News, Understand It.

Selvita image

News from Selvita

Your destination for news from Selvita. See how Selvita’s media bias impacts the breaking news stories of today.

We’ve aggregated 7 of Selvita’s headlines and news stories over the past 3 months.

Selvita’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Selvita’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Selvita

Where is Selvita located?Selvita's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Selvita News

Submission of Candidates to the Company’s Supervisory Board

Kraków · Kraków

Submission of Candidates to the Company’s Supervisory Board

The Management Board of Selvita S.A., with its registered office in Kraków (the “Company”), hereby informs that, in connection with the convening of the Ordinary General Shareholders’ Meeting of the Company for June 30, 2025, as announced in Current Report No. 8/2025 dated June 4, 2025, which agenda includes, among others, the adoption of resolutions regarding the appointment of members of the Company’s Supervisory Board, the Company has receive…Read Article

Convening of the Ordinary General Shareholders Meeting of Selvita S.A.

Kraków · Kraków

Convening of the Ordinary General Shareholders Meeting of Selvita S.A.

The Management Board of Selvita S.A. with its registered office in Krakow (“Company”) acting pursuant to Art. 399 § 1, art. 4021 and art. 4022 of the Commercial Companies Code, hereby gives a notice that Annual General Meeting of Shareholders will be held on June 30, 11:00 AM, at ul. Podole 79, 30-394 Kraków. Agenda: Opening of the session. Election of the Chairman of the Meeting. Statement by the Chairman of the correctness of convening the …Read Article

Notifications from persons closely associated with a person discharging managerial responsibilities in the Company

Kraków · Kraków

Notifications from persons closely associated with a person discharging managerial responsibilities in the Company

The Management Board of Selvita S.A. with its registered office in Kraków (“Company”) hereby informs that on June 2, 2025, the Company received two notifications prepared in accordance with Article 19.1 of MAR from AUGEBIT Fundusz Inwestycyjny Zamknięty managed by FORUM TFI S.A. with its registered office in Kraków, and from the Fundacja Rodziny Wesołowskich Fundacja Rodzinna w Krakowie, as persons closely associated with Mr. Tadeusz Wesołowski …Read Article

Selvita Acquires License for Medicines Discovery Catapult’s Patented Target Engagement Technology

The Chemical Protein Stability Assay generates vital data to support drug discovery innovators and will enhance Selvita’s screening platform Kraków, Poland – 27 May 2025 – Selvita is the first contract research organisation (CRO) to license a Chemical Protein Stability Assay developed and patented by Medicines Discovery Catapult (MDC) to help identify and prioritise drug candidates faster. MDC’s Chemical Protein Stability Assay (CPSA) is a disti…Kraków · Kraków Read Article

Corporate Presentation: Q1 2025 Financial Results

The post Corporate Presentation: Q1 2025 Financial Results appeared first on Selvita.Read Article

Selvita Group Consolidated Quarterly Report: 2025 Q1

The post Selvita Group Consolidated Quarterly Report: 2025 Q1 appeared first on Selvita.Read Article

Receipt of a significant purchase order by a company affiliated with Selvita S.A.

The Management Board of Selvita S.A., with its registered office in Krakow (the “Issuer” or the “Company”), hereby informs that, in connection with current report no. 8/2024 (the “Report”), the Issuer affiliated company, Selvita Inc., has received a statement of work (the “Order”) from a U.S.-based biopharmaceutical company (the “Client”). The order concerns the continuation of work on the Client’s fully integrated oncology drug discovery progra…Poland · Poland Read Article

You've scrolled to the bottom of the feed, there are no more stories.